These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30394366)

  • 1. Tangshen Formula Treatment for Diabetic Kidney Disease by Inhibiting Racgap1-stata5-Mediated Cell Proliferation and Restoring miR-669j-Arntl-Related Circadian Rhythm.
    Wang X; Zhao H; Wu X; Xi G; Zhou S
    Med Sci Monit; 2018 Nov; 24():7914-7928. PubMed ID: 30394366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression.
    Zhao H; Li X; Zhao T; Zhang H; Yan M; Dong X; Chen P; Ma L; Li P
    PLoS One; 2017; 12(2):e0171475. PubMed ID: 28182710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
    Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
    BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial genes associated with diabetic nephropathy explored by microarray analysis.
    Wang Z; Wang Z; Zhou Z; Ren Y
    BMC Nephrol; 2016 Sep; 17(1):128. PubMed ID: 27613243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes for diabetic kidney disease using biological informatics methods.
    Ma F; Sun T; Wu M; Wang W; Xu Z
    Mol Med Rep; 2017 Dec; 16(6):7931-7938. PubMed ID: 28990106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.
    Cui C; Cui Y; Fu Y; Ma S; Zhang S
    Mol Med Rep; 2018 Feb; 17(2):2161-2168. PubMed ID: 29207157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of mechanisms of mesenchymal stem cells for treatment of diabetic nephropathy via construction of a miRNA-TF-mRNA network.
    Yang H; Zhang X; Xin G
    Ren Fail; 2018 Nov; 40(1):136-145. PubMed ID: 29532746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.
    Guan D; Tian H
    World J Surg Oncol; 2017 Sep; 15(1):177. PubMed ID: 28934958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy.
    Hu J; Fan X; Meng X; Wang Y; Liang Q; Luo G
    Planta Med; 2014 Jun; 80(8-9):614-21. PubMed ID: 24853762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irbesartan ameliorates diabetic kidney injury in
    Zhao H; Li Z; Yan M; Ma L; Dong X; Li X; Zhang H; Li P
    J Transl Int Med; 2024 Apr; 12(2):157-169. PubMed ID: 38799791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irbesartan ameliorates diabetic kidney injury in
    Zhao H; Li Z; Yan M; Ma L; Dong X; Li X; Zhang H; Li P
    J Transl Int Med; 2024 Apr; 12(2):157-169. PubMed ID: 38779121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated microRNA‑gene analysis of coronary artery disease based on miRNA and gene expression profiles.
    Xu X; Li H
    Mol Med Rep; 2016 Apr; 13(4):3063-73. PubMed ID: 26936111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic Analysis of Genes and MicroRNAs Associated With Atrioventricular Septal Defect in Down Syndrome Patients.
    Wang L; Li Z; Song X; Liu L; Su G; Cui Y
    Int Heart J; 2016 Jul; 57(4):490-5. PubMed ID: 27396555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis.
    Fan Y; He J; Shi L; Zhang M; Chen Y; Xu L; Han N; Jiang Y
    Acta Diabetol; 2024 Aug; 61(8):1053-1068. PubMed ID: 38691241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
    Chen J; Luo SF; Yuan X; Wang M; Yu HJ; Zhang Z; Yang YY
    J Cell Biochem; 2022 Feb; 123(2):481-492. PubMed ID: 34908186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.